Wolverine Asset Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,635
| Closed | -$26.3K | – | 1968 |
|
|
2022
Q4 | $26.3K | Sell |
2,635
-1,275
| -33% | -$12.7K | ﹤0.01% | 1117 |
|
|
2022
Q3 | $39K | Sell |
3,910
-90
| -2% | -$898 | ﹤0.01% | 1339 |
|
|
2022
Q2 | $40K | Hold |
4,000
| – | – | ﹤0.01% | 1360 |
|
|
2022
Q1 | $39K | Buy |
+4,000
| New | +$39K | ﹤0.01% | 1359 |
|
|
2021
Q2 | – | Sell |
-1,107
| Closed | -$11K | – | 2303 |
|
|
2021
Q1 | $11K | Sell |
1,107
-2,253
| -67% | -$22.4K | ﹤0.01% | 1593 |
|
|
2020
Q4 | $35K | Buy |
+3,360
| New | +$35K | ﹤0.01% | 1088 |
|